BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

UTime Signs NDA for Strategic Acquisition of Bowen Therapeutics Lab to Boost Global Vaccine Development

UTime Limited has officially announced the signing of a non-disclosure agreement (the "NDA") with Bowen Therapeutics Inc ("Bowen Therapeutics") for th...

August 29, 2024 | News

Hilleman Laboratories and Bharat Biotech Introduce HILLCHOL®: A Pioneering Oral Cholera Vaccine Set to Transform Global Health

Hilleman Laboratories, in partnership with Bharat Biotech,announced the successful launch of HILLCHOL®, a groundbreaking oral cholera vaccine (OCV) t...

August 28, 2024 | News

Everest Medicines Launches First Clinical Trial for Personalized mRNA Cancer Vaccine EVM16 in China

Everest Medicines , a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeut...

August 22, 2024 | News

Pfizer and BioNTech Announce Mixed Results from Phase 3 Trial of Combination mRNA Vaccine for Influenza and COVID-19

Pfizer Inc. and BioNTech SE announced top-line results from their Phase 3 clinical trial to evaluate the companies’ combined mRNA vac...

August 19, 2024 | News

WestGene Biopharma's mRNA Cancer Vaccine WGc-043 Receives Dual IND Approvals from China and US

WestGene Biopharma is proud to announce that its mRNA therapeutic cancer vaccine, WGc-043, has received dual IND approvals from China's National ...

August 08, 2024 | News

NEC Bio Therapeutics and AGC Biologics Partner to Enhance Production of Personalized Cancer Vaccine

NEC Bio Therapeutics and AGC Biologics have announced a partnership to advance the production of NECVAX-NEO1, an orally delivered, bacteria-based D...

August 08, 2024 | News

Pfizer Announces Launch of Bivalent RSV Vaccine in Hong Kong and Macau

Pfizer Inc. has announced the availability of its bivalent RSV prefusion F (RSVpreF) vaccine in Hong Kong this month. Approved by health authorities in Hon...

July 19, 2024 | News

Indian Immunologicals Donates 10,000 Doses of Anti-Rabies Vaccine to Vulnerable Communities in Vietnam

Indian Immunologicals Ltd (IIL), led by its Chairman Dr. Meenesh Shah and Managing Director Dr. K. Anand Kumar, has generously donated 10,000 doses of its ...

July 17, 2024 | News

Sabin Vaccine Institute Launches Phase 2 Trial for Sudan Ebolavirus Vaccine in Uganda

Sabin Vaccine Institute launched a Phase 2 clinical trial for its vaccine against Sudan ebolavirus, with healthy volunteers receiving the single-...

July 16, 2024 | News

Merck and Afrigen Partner in South Africa to Develop mRNA Platform Technology, Boosting Global Vaccine Access

Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization Contributes to expand...

July 05, 2024 | News

PharmaJet’s Needle-Free Tropis® System to Drive House-to-House Polio Immunization Campaign in Somalia

PharmaJet®, a company dedicated to enhancing the performance and outcomes of injectables through innovative delivery systems, today announced that thei...

June 28, 2024 | News

Pfizer and BioNTech's Omicron JN.1 COVID-19 Vaccine Receives CHMP Recommendation

The updated COVID-19 vaccine is tailored to the Omicron JN.1 lineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older Re...

June 28, 2024 | News

ILiAD Biotechnologies Selects Emmes Group for Global Phase III Trials of BPZE1 Pertussis Vaccine

Multiple Phase III studies are expected to be conducted across North America, Central and South America, UK and other global clinical sites VaxTrials, p...

June 25, 2024 | News

FDA Approves GSK's AREXVY Vaccine for High-Risk Adults Aged 50-59

Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes1 Clinical development program conti...

June 10, 2024 | News

Stay Connected